Skip Navigation

About Adam

Adam advises clients on a variety of capital markets transactions, including financings, public offerings and private placements of securities, as well as mergers and acquisitions. He also advises clients on corporate governance and securities regulatory matters, including the continuous disclosure obligations of public issuers.

Prior to joining Blakes, Adam practiced in the Toronto office of an international law firm, providing corporate and securities law advice.

Select Experience

Recent M&A, capital markets and private equity transactions include advising:

  • A syndicate of underwriters on the $28.8-million bought deal offering of common shares of Enterprise Group, Inc.

  • goeasy Ltd. in connection with its offering of US$400-million and C$150-million senior unsecured notes due 2030, and a tender offer to purchase any and all of its outstanding senior unsecured notes due 2026

  • GrowthCurve Capital Management on its majority investment in PureFacts Financial Solutions, a leading provider of wealth management software

  • AstraZeneca AB on its US$2.4-billion acquisition of Fusion Pharmaceuticals Inc.

  • TrueContext Corporation, a global leader in field intelligence, on its acquisition by Battery Ventures, in a transaction valuing the company at C$150-million

  • A syndicate of international financial institutions in connection with the issuance of a C$750-million maple bond offering

  • A leading Japanese trading house in connection with its investment in a Quebec-based graphite company

 

Education

Admitted to the Ontario Bar – 2020
JD, Osgoode Hall Law School – 2019
BA (With Distinction), McGill University – 2016

More insights

Save Profile

Select sections to customize your PDF

Cancel